| 标题 |
[求助补充材料]
Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/oesophageal adenocarcinoma (CheckMate 649): a multicentre, randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Y. Janjigian; K. Shitara; M. Moehler; M. Garrido; P. Salman; et al 出版日期:2021-06-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)